Syra Health (SYRA) Registration Filing summary

Company overview and business model

• Operates as a healthcare services company focused on preventative health, holistic wellness, health education, and equitable care across all demographics.

• Offers end-to-end solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce services.

• Develops digital and AI-driven platforms, such as Syrenity for mental health and SyraBot for patient engagement, with plans to launch new products in 2024.

• Targets payers, providers, life sciences, academic institutions, and government agencies as clients.

• Growth strategy includes expanding geographically, investing in partnerships, and potential acquisitions to enhance service lines.

Financial performance and metrics

• Reported revenues of $3.7M for the six months ended June 30, 2024, and $5.5M and $5.6M for the years ended December 31, 2023 and 2022, respectively.

• Net losses were $2.84M (six months ended June 30, 2024), $2.94M (2023), and $2.12M (2022); accumulated deficit reached $7.9M as of June 30, 2024.

• Cash balance was $1.59M as of June 30, 2024; company expects current cash and revenue to fund operations for at least 12 months from the latest financial statement date.

• Auditor expressed substantial doubt about ability to continue as a going concern without additional capital.

Use of proceeds and capital allocation

• Estimated net proceeds of $4.3M (assuming $1.32 per share offering price) after fees and expenses.

• Proceeds intended for marketing and sales, application development, R&D, general corporate purposes (including working capital, operating expenses, and capital expenditures), and potential acquisitions or in-licensing.

• Management retains broad discretion over allocation of proceeds.